Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry

Author:

Mazzitelli Maria1ORCID,Pontillo Domenico2,Clemente Tommaso23ORCID,Di Biagio Antonio45ORCID,Cenderello Giovanni6,Rusconi Stefano7ORCID,Menzaghi Barbara8,Fornabaio Chiara9,Garlassi Elisa10,Zazzi Maurizio11,Castagna Antonella23,Cattelan Anna Maria1, ,Castagna Antonella,Spagnuolo Vincenzo,Galli Laura,Maggiolo Franco,Calza Leonardo,Focà Emanuele,Lagi Filippo,Cenderello Giovanni,Di Biagio Antonio,Marchetti Giulia,Rusconi Stefano,Cervo Adriana,Gagliardini Roberta,Bonora Stefano,Cattelan Anna Maria,Zazzi Maurizio,Santoro Maria Mercedes,Zazzi Maurizio,Santoro Maria Mercedes,Galli Andrea,Saladini Francesco,Armenia Daniele,Carini Elisabetta,Bagaglio Sabrina,Galli Laura,Lolatto Riccardo,Diotallevi Sara,Tavio Marcello,Paggi Alessandra Mataloni,Ripoli Bagno A,Vichi Francesca,Bellucci Alessio,Mirabelli Elisa,Saracino Annalisa,Balena Flavia,Maggiolo Franco,Comi Laura,Valenti Daniela,Suardi Claudia,Calza Leonardo,Malerba Federica,Castelli Francesco,Focà Emanuele,Minisci Davide,Pennati Francesca,Celotti Anna,Brognoli Francesca,Menzaghi Barbara,Farinazzo Maddalena,Cacopardo Bruno,Celesia Benedetto Maurizio,Raddusa Michele Salvatore Paternò,Giarratana Carmen,Torti Carlo,Fusco Paolo,Bruno Gabriele,Pan Angelo,Brambilla Paola,Fornabaio Chiara,Bartoloni Alessandro,Giachè Susanna,Corsi Paola,Kiros Seble Tekle,Lagi Filippo,Ducci Filippo,Santantonio Teresa,Caputo Sergio Lo,Ferrara Sergio,Narducci Marianna,Pontali Emanuele,Feasi Marcello,Sarà Antonio,Bassetti Matteo,Di Biagio Antonio,Blanchi Sabrina,Castagna Antonella,Spagnuolo Vincenzo,Carini Elisabetta,Bagaglio Sabrina,Galli Laura,Lolatto Riccardo,Galli Andrea,Clemente Tommaso,Borjesson Rebecka Papaioannu,Diotallevi Sara,Antinori Spinello,Formenti Tiziana,Giacomelli Andrea,Marchetti Giulia,Gazzola Lidia,De Flaviis Federica,Puoti Massimo,Moioli Cristina,D’Amico Federico,Mussini Cristina,Cervo Adriana,Enrica Roncaglia,Giulia Nardini,Beghetto Barbara,Manzillo Elio,Lanzardo Amedeo,Cattelan Anna Maria,Mazzitelli Maria,Cascio Antonio,Trizzino Marcello,Fronti Elisa,Laccabue Diletta,Gulminetti Roberto,Zuccarini Andrea,Francisci Daniela,Schiaroli Elisabetta,De Socio Giuseppe,Garlassi Elisa,Corsini Romina,Gagliardini Roberta,Fusto Marisa,Sarmati Loredana,Malagnino Vincenzo,Lamonica Silvia,Di Giambenedetto Simona,Mulas Tiziana,Cenderello Giovanni,Pincino Rachele,Tumbarello Mario,Fabbiani Massimiliano,Panza Francesca,Rancan Ilaria,Di Perri Giovanni,Bonora Stefano,Ferrara Micol,Fantino Silvia,Malena Marina,Fiscon Marta

Affiliation:

1. Infectious and Tropical Diseases Unit, Padua University Hospital , Padua , Italy

2. Clinic of Infectious Diseases, Vita-Salute University, San Raffaele Scientific Institute , Milan , Italy

3. Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Raffaele Hospital , Milan , Italy

4. Clinica Malattie Infettive, IRCCS Ospedale Policlinico San Martino , Genova, Liguria , Italy

5. Department of Health Sciences (DiSSal), University of Genoa , Genoa , Italy

6. Infectious Disease Unit, Sanremo Hospital, ASL 1 Imperiese , Sanremo , Italy

7. Infectious Diseases Unit, ASST Ovest Milanese, Legnano General Hospital , Legnano , Italy

8. Unit of Infectious Diseases, ASST della Valle Olona , Busto Arsizio , Italy

9. Infectious Diseases Unit, ASST Cremona , Cremona , Italy

10. Malattie Infettive Arcispedale S. Maria Nuova-IRCSS , Reggio Emilia , Italy

11. Department of Medical Biotechnologies, University of Siena , Siena , Italy

Abstract

Abstract Objectives To evaluate polypharmacy, anticholinergic burden (ACB) and drug–drug interactions (DDIs) in people with four-class-resistant HIV (4DR-PWH). Methods We performed a cross-sectional study, including 4DR-PWH from the PRESTIGIO Registry taking at least one non-antiretroviral drug. Polypharmacy was defined as taking five or more non-antiretroviral drugs. ACB was calculated using the ACB scale: 0 = no AC effect, 1–2 = low/moderate risk, ≥3 = high AC risk. Participants’ characteristics by ACB score were compared using the Kruskal–Wallis test, and Spearman's correlation coefficient was used to assess linear relationships. DDIs were evaluated using the Liverpool database. Results Overall, 172 4DR-PLWH were evaluated: 75.6% males, median age 49.9 years (IQR = 45.6–56), 62 (27.1%) on polypharmacy, 124 (72.1%) using a boosting agent and 72 (41.8%) with four or more antiretrovirals. Based on ACB, 128 (74.45%), 33 (19.2%) and 11 (6.4%) had a no, low/moderate and high AC risk, respectively. The most common AC drugs were β-blockers (12.2%), diuretics (8.7%) and antidepressants (8.7%). The high ACB was significantly related to the number of drugs/person (r = 0.33, P < 0.0001) and the number of clinical events (r = 0.222, P = 0.004). Overall, 258 DDIs were found between antiretrovirals and co-medications in 115 (66.8%) PWH, and 14 (8.1%) PWH received contraindicated drug combinations. Conclusions In 4DR-PWH, polypharmacy, DDIs and the proportion of people with moderate/high AC burden were high. In 4DR-PWH undetectability achievement and maintenance is the priority and use of boosted PIs is common. A strict collaboration (infectious diseases specialists, virologists, pharmacologists) is needed to limit the risk of ACB and DDIs and to explore the advantages of new antiretrovirals.

Funder

Gilead Sciences

ViiV Healthcare

Theratecnologies

Merck Sharp & Dohme

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3